Team Glooko will be at the American Diabetes Association’s 2026 Clinical Update Conference from February 6 to 8 in Houston, Texas, showcasing how our inpatient and outpatient solutions are helping hospitals and health systems address the growing challenge of glycemic safety and diabetes management and advancing team-based diabetes care.
Through our recent acquisition of Monarch Medical Technologies, we are now uniquely positioned to reduce glycemic risk, improve patient safety, and support overburdened clinical teams through coordinated expertise across the full continuum of care.
Here’s what you can learn about the Glooko diabetes management platform and EndoTool Glucose Management System, developed by Monarch Medical Technologies, a Glooko Company, at booth 17.
- How to move from data overload to workflows that actually work: Disconnected systems, manual PDFs, and multiple logins slow care teams down and increase risk. Our EHR-integrated diabetes workflows in Glooko and EndoTool reduce manual burden, improve visibility, and enable consistent care across clinical, education, and operational teams.
- Methods for preparing for mandatory CMS glycemic reporting: Hospitals are preparing for mandatory severe hypo- and hyperglycemia reporting from the Centers for Medicare & Medicaid Services. EndoTool, our patient-specific insulin dosing system, helps hospitals achieve unmatched clinical outcomes, reduce variability, and support CMS readiness with confidence.
- Ways we align with the 2026 ADA Standards of Care: We’re helping clinicians and health systems turn the American Diabetes Association’s 2026 Standards of Care into reality. By streamlining data, enhancing team-based diabetes care, and delivering actionable insights, we’re bridging the gap between clinical guidelines and measurable outcomes to improve life for patients and their healthcare providers.
- Tools for improving diabetes population health management: Designed for busy diabetes care team members, Glooko’s user-friendly clinic dashboard, now available in select countries, provides quick insights into patient trends and key clinic metrics to help clinics, hospitals, and health systems achieve better enterprise-wide diabetes management.
Leverage the power of team-based diabetes care
Schedule a demo with one of our experts at the ADA Clinical Update to see how your team can benefit from our innovative digital health platforms.
EndoTool is developed and marketed by Monarch Medical Technologies, a Glooko Company. EndoTool is an FDA-cleared Class II medical device indicated for inpatient use as described in its Instructions for Use. Glooko’s diabetes management platform and EndoTool are currently independent solutions. Patient-specific refers to EndoTool’s ability to use available patient information within the hospital’s electronic medical record to provide individualized insulin dosing recommendations. Recommendations are intended to assist, not replace, clinical judgment. All treatment decisions remain the responsibility of the licensed healthcare provider.